Laird Norton Wetherby Trust Company, LLC
BankPosition in ALNY — Alnylam Pharmaceuticals, Inc.
CIK 723204
Seattle, WA
Position in ALNY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$993,398
-$166,962 QoQ
Shares Held
3,300
-5.9% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#400
of 784 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 2%
Shared 0%
None 98%
Common Shares in ALNY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Laird Norton Wetherby Trust Company, LLC holds $18,816,907 across 20 Biotechnology names. ALNY ranks #6 (5.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
11,528 | $5,726,302 | |
| 2 | ARGX |
Argenx SE
|
2,282 | $2,117,170 | |
| 3 | ANIX |
Anixa Biosciences Inc
|
578,727 | $1,620,435 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,419 | $1,508,342 | |
| 5 | RPRX |
Royalty Pharma plc
|
19,424 | $1,089,102 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
This page
|
3,300 | $993,398 | |
| 7 | INCY |
Incyte Corp
|
7,051 | $799,300 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
4,060 | $760,356 |
All Filings in ALNY
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $993,398 | 3,300 | Shares | Other | 2026-08-14 | |
| 2026-03-31 | $1,160,360 | 3,507 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $1,392,172 | 3,501 | Shares | Sole | 2026-02-17 | |
| No filing history on record for this holder in this stock. | ||||||